Deciphering the complex network structure is crucial in drug target identification. This study presents a framework incorporating graph theoretic and network decomposition methods to analyze system-level properties of the comprehensive map of the epidermal growth factor receptor (EGFR) signaling, which is a good candidate model system to study the general mechanisms of signal transduction. The graph theoretic analysis of the EGFR network indicates that it has small-world characteristics with scale-free topology. The employment of network decomposition analysis enlightened the system-level properties, such as network cross-talk, specific molecules in each pathway and participation of molecules in the network. Participating in a significant fraction of the fundamental paths connecting the ligands to the phenotypes, cofactor GTP and complex Gb/Gc were identified as ''housekeeping" molecules, through which all pathways of EGFR network are cross-talking. c-Src-Shc complex is identified as important due to its role in all fundamental paths through tumorigenesis and being specific to this phenotype. Inhibitors of this complex may be good anti-cancer agents having very little or no effect on other phenotypes.
Introduction
Mammalian cells integrate information from complex intracellular signal transduction pathways to make decisions in response to changes in the environment. Signaling molecules and their networks play important roles in molecular diagnosis and therapy of diseases as almost all known diseases exhibit some kind of dysfunction at transcriptional level. There has been a great deal of enthusiasm to identify novel drug targets based on knowledge of key signal transduction components which have links to diseases. Elucidating cellular signaling is central for gaining insight into the molecular mechanisms behind diseases as well as adaptation of living cells to changes in the environment. In recent years the high-throughput techniques such as transcriptomics, proteomics and metabolomics enabled the collection of genome scale experimental data and lead to the reconstruction of large-scale signaling networks [1] [2] [3] .
A very important signaling mechanism in mammalian cells is the epidermal growth factor receptor (EGFR) signaling which regulates processes such as growth, survival, proliferation and differentiation. The malfunctions in this signal transduction network may lead to uncontrolled cell proliferation resulting in tumor formations. It may also cause diseases with immunological, inflammatory and degenerative syndromes [4] . Therefore the unraveling of EGFR signaling mechanism is vital for the identification of potential drug targets and also for understanding of design principles of signaling mechanisms in development and tissue homeostasis [5, 6] . The mechanism of the EGFR signaling has been analyzed thoroughly both experimentally and computationally to uncover the unknowns about general principles of signal transduction processes including receptor-mediated endocytosis, oncogenesis, mitogen-activated protein kinase (MAPK) signaling pathways, multi-receptor family interactions, autocrine loops and receptor transactivation [7] . Although lots of computational models have been developed for the EGFR signaling system [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] only a limited part of the system was modeled before Oda and coworkers' work [2] in which the most comprehensive pathway map for EGFR-induced and related pathways was published. It has the overall bow-tie structure that is a characteristic of the robust evolvable systems [20] . This structure implies that a variety of ligands bind to corresponding receptors, leading to diverse phenotypes via activations of the intermediate signaling molecules in the network [2] . Small-scale models were used as the basis for a dynamic analysis of EGFR signaling with determined kinetic parameters [15, 19, 21, 22] . Large-scale stoichiometric models, on the other hand, give information on the architectural feature of the signaling network [2] .
The structure-oriented analyses usually provide valuable insight into the mechanisms of the networks by defining 1532-0464/$ -see front matter Ó 2008 Elsevier Inc. All rights reserved. doi:10.1016/j.jbi. 2008 .08.008 function-structure relationships [23] . Although structural analysis of metabolic networks is a well-established field, relatively few methods have been proposed so far to analyze structural properties of interaction and signaling networks [24] . In the last decade, methods derived from graph theory have been developed to understand the structure of the systems of molecular interactions [25, 26] . In this study, the graph theoretic analysis was performed to detect the components that are well or poorly connected in the interaction network and thus it may be a useful guide for experimental studies on protein interactions. Moreover, time-invariant topological structure of the network were decomposed into a system of linear paths [27, 28] connecting ligands to each phenotype. The signaling molecules involved in the linear paths and the path lengths provided system-level information on the signaling network allowing us to observe network cross-talk (shared molecules in linear paths leading to diverse phenotypes), molecules specific to each phenotype and participation of molecules in signaling pathways. Using all these information, one may identify drug targets for cancer by inhibiting molecules involved in linear paths leading to tumor formation or by inducing molecules involved in linear paths going to apoptosis.
Materials and methods

The map of EGFR-mediated signaling network
The map of EGFR signaling network [2] analyzed here consists of EGFR endocytosis with its degradation or recycling, small guanosine triphosphatase (GTPase)-mediated signal transduction such as mitogen-activated protein kinase (MAPK) cascade, phosphatidylinositol polyphosphate (PIP) signaling, cell cycle, and G protein-coupled receptor (GPCR)-mediated EGFR transactivation via intracellular Ca 2+ signaling (a simplified but descriptive version of the map of [2] is given as Fig. 1 (phenotypes) such as apoptosis, migration via actin reorganization, cell cycle progression, transcriptional regulation of downstream genes, tumorigenesis (production of a tumor) and mitogenesis (induction of mitosis) [2] .
Graph theoretic analysis
The first step in a graph theory based analysis is the mathematical representation of an interaction network as a graph where nodes are signaling molecules and edges connecting nodes are interactions. The second step is to determine graph properties of the network using graph theoretic techniques. These properties are the degree (connectivity) of nodes, the number of hubs (highly connected nodes) and the shortest path lengths between indirectly connected nodes [34] . Before the studies in the last decade [25] [26] [35] [36] [37] [38] [39] [40] [41] complex networks were modeled using classical random network theory [42, 43] which assumes that nodes in the network are connected with each other randomly with a probability p. This theory results in random homogenous networks in which k values (connectivity) show a Poisson distribution where the peak is at <k> (average connectivity) and the probability of finding a highly connected node decays exponentially (P(k) % e Àk for k >> <k>). In fact biological networks are heterogeneous in nature and there are a few highly connected nodes (hubs) that link the less connected nodes to the network (scale-free nature) following a power law model (P(k) % k Àc ) [25] . Biological networks also have small-world architectures with relatively short paths between any two nodes despite their large sizes [38] . In our work, the graph properties were determined using the algorithm of Arga and coworkers [28] implemented in MATLAB 7.0. The input to the algorithm is the adjacency matrix (S), which is a binary, square matrix representing the edges between nodes. S(i,j) = 1, if (i,j) is an interacting molecule pair, otherwise S(i,j) = 0. The state transition diagram of EGFR signaling network is represented by this adjacency matrix where the molecules in a reaction are considered as interacting pairs. The element of the nth power of the adjacency matrix, S n (i,j), gives the number of paths with path length of n from molecule i to molecule j. During the calculation of successive powers of the adjacency matrix, the first nonzero value of S(i,j) is the shortest path length between molecules i and j. Mean path length and the diameter of the network are calculated as the average and maximum of shortest path lengths, respectively.
Network decomposition analysis
Network decomposition analysis includes decomposition of a network into fundamental paths through linear combination of which the time-invariant topological structure can be captured [28] . It is shown to be useful to define the structure of the network and the overall capabilities of the cell [44] [45] [46] [47] [48] [49] . In this study, among the various decomposition techniques, linear path analysis was chosen for the structural investigation of the EGFR signaling network since the number of fundamental routes for small-world, large-scale networks such as EGFR signaling network [2] is very high and computationally unmanageable with other pathway analysis methods reported in literature [27, 44, 47] . As opposed to elementary flux modes [44, 48, 49] and extreme pathways [47] , the number of linear paths [27] connecting inputs to outputs of the network can be limited by specifying the maximum path length in the calculation procedure.
In order to investigate the topology of the EGFR signaling network, linear paths connecting ligands to phenotypes were determined using NetSearch algorithm [27] . The EGFR signaling map [2] was converted into a protein-protein interaction graph by using directed interactions between reactants-products and modifiers-products of the same reaction (the direction is always towards the products of the reactions) regardless of whether modifier-product interaction describes an activation or deactivation (see Supplementary material). This graph was then used as the input to the NetSearch algorithm. In addition to this interaction (connectivity) information, inputs (ligands) and outputs (phenotypes as cellular responses) were defined for the linear path calculations. The linear path analysis was performed to get information about network cross-talk, specific molecules for each phenotype and participation of signaling molecules in the pathways of the EGFR signaling network.
The NetSearch algorithm [27] allows user to define the length of the longest linear paths in the calculation procedure. We observed that, the number of linear paths increases exponentially with maximum path length for all phenotypes. Using the following exponential relationship between the number of linear paths (n) and the maximum path length (l),
we determined the exponential coefficient, b, which is an indicator of the complexity of the regulation of the phenotypes. Larger b means more linear paths with the same path length, i.e. more alternative signaling routes. In Eq. (1), l min is the minimum path length giving at least one linear path for the corresponding phenotype, and a is the number of linear paths at the minimum path length
Common (network cross-talk) and specific molecules were defined as identical molecules used in linear paths targeting diverse phenotypes and molecules used in linear paths targeting only one phenotype, respectively. Finally, molecule participation in the network was considered as participation percentages of the molecules in the linear paths of each phenotype.
Pathway logic
Pathway logic is an approach to model biological processes based on rewriting logic (uses rewriting logic language Maude). It allows modeling and symbolic analysis of signaling and metabolic networks enabling the user to visualize the network in Petri nets format [50] . This approach enables researchers to understand complex biological systems by in silico experiments and accelerates the design of in vivo experiments to test the findings. Using formal methods tools of pathway logic, biological networks can be queried. For a chosen initial condition, it shows all pathways leading to a specified final condition [51] . In this work, we tested the results of network decomposition analysis by pathway logic. The EGFR network was implemented in Maude (http://maude.csl.sri.-com) defining species and reactions and, the network was queried by the pathway logic assistant [50] . The critical molecules for each phenotype found from network decomposition analysis were analyzed by deleting them and observing their effects on the corresponding phenotypes.
Results and discussion
Graph theoretic analysis
The EGFR signaling network [2] was represented by an undirected interaction graph with 329 nodes and 1795 edges connecting them. Using the algorithm [28] mentioned in Section 2.2, the network diameter and the mean path length were calculated as 11 and 4.7, respectively. These results indicate that any two nodes in the system can be connected by relatively short paths along existing links despite of large size of the EGFR signaling network. In other words, the EGFR-mediated signal transduction network has small-world architecture that is a general feature of many complex biological networks [52] . The small-world topology of the signaling network may lead to shorter transition times between different states [38] . Comparative analysis of graph theoretic properties of the EGFR network with those of other protein interaction networks reported in literature (Table 1) indicates significant similarity especially between distance measures, i.e. mean path length and network diameter. It was found that the connectivity (k, the number of links per node) distribution of the nodes in the graph has a scale-free nature (Fig. 2) following nearly a power law model (P(k) % k Àc c = 1.86 with R 2 = 0.84) which is a general characteristics of biological networks [25, 53] as well as World-Wide Web [35, 54] , social networks [39] and scientific collaboration networks [55] . The nodes in Fig. 2 were analyzed statistically by Essential Regression ver. 2.2 and the small number of nodes having only one link to the network was determined as an outlier point and therefore excluded in the inner diagram of Fig. 2 . The hubs in EGFR-mediated signaling network were found as the complex of ErbB1 ligand-active EGFR, the co-factors, GTP (guanosine triphosphate) and GDP (guanosine diphosphate), and Gb/Gc (b/c subunits of the heterotrimeric G-protein) having 36, 31, 31 and 29 connectivities, respectively. GTP, GDP and Gb/Gc are involved in GPCR (G protein-coupled receptor)-mediated EGFR transactivation. This result is in agreement with the literature information that the GPCRs are involved in all types of signaling pathways. Therefore their malfunctions cause many pathological conditions and now the GPCRs are targets of 40-50% of all modern medicinal drugs [56] .
Linear paths of the bow-tie structured EGFR network
The molecular interactions of a network can be used for a systemic analysis of input/output relationships via linear paths starting from ligands ending at phenotypes. The NetSearch algorithm [27] gives the number of linear paths with their length (the number of interactions in each path). For the phenotypes of tumorigenesis and mitogenesis, all steps in the network are same except the last one going towards the corresponding end-phenotypes. Hence in network decomposition analysis of the EGFR network, tumorigenesis and mitogenesis were considered as one phenotype (tumorigenesis-mitogenesis) throughout this study.
The shortest path lengths were calculated for each phenotype (Fig. 3) . The maximum of the shortest path lengths was found as 14 which give the network diameter for the phenotypes in the EGFR signaling network, i.e. in 14 molecular interactions (state transitions) the ligands can be linked to all phenotypes through signaling molecules. This value is higher than the network diameter of 11 obtained from graph theoretic analysis (Section 3.1). The difference in network diameters is due to the fact that the adjacency matrix (input of the graph theoretic calculations) is undirected whereas the interaction graph (input of the NetSearch algorithm) is directed. In order to obtain information about the complexity of the regulation of the phenotypes by a comparative analysis among the phenotypes, we obtained quantitative data by changing the maximum path lengths and observing the resultant number of linear paths for each phenotype ( Table 2 ). The exponential increase in the number of linear paths with maximum path length for each phenotype can be visualized when the results are plotted in Fig. 4 . Using Eq. (1) and the data in Table 2 exponential coefficients (b) were determined for each phenotype (Table 3 ). Owing to their higher exponential coefficients one can state that apoptosis and cell cycle progression as cell responses of EGFR signaling have more complex regulation mechanisms in EGFR signaling network. In other words, the flowing signal has more alternative routes through these phenotypes. There are intimate links between cellular complexity and robustness which is the ability to maintain performance in the face of perturbations [57] . This fact increases the insensitivity of apoptosis and cell cycle progression against any mutations in the signaling molecules having the larger b values. Each day around 50-70 billion cells die in an average human adult, and on a yearly basis apoptosis of this amount of cell corresponds to the weight of an average human body [58] . On the other hand, cell cycle response (cell-division cycle) being responsible for cellular differentiation during embryogenesis, morphogenesis and maintenance of stem cells during adult life is also widespread in nature [59] .
Network cross-talk
The structure of the EGFR signaling network was captured as a system of linear paths (2nd column of Table 2 ). In order to comprehensively analyze the reactions and molecules included in these linear paths, the number of linear paths was constrained to around 200 since this amount of paths includes most of the molecules (at least once) in the EGFR signaling network and hence is expected to give statistically meaningful information about network cross-talk, molecules specific to the phenotypes and molecule participation in pathways discussions.
The linear paths of a network allow a quantitative evaluation of network cross-talk by observing identical molecules involved in linear paths leading to diverse responses. Various definitions and measures of cross-talk have been described in the literature taking into account structural and dynamic aspects [1, [60] [61] [62] [63] [64] [65] . Here, we accept the classical definition in which sharing of identical signaling molecules in different signaling pathways is used as a measure of cross-talk [60] . It was observed that the cofactor GTP and the complex Gb/Gc are involved in more than 70% of the linear paths through all phenotypes in the network. All pathways leading to a phenotype in the EGFR signaling network are cross-talking through these signaling molecules. It can therefore be stated that these molecules are crucial for the continuity of the signal transduction as their deficiencies may prevent most of the linear paths for all phenotypes to be completed. For each phenotype, the molecules involved in more than 50% of the linear paths were considered and among them the molecules that are shared between different pathways (i.e. cross-talking pathways) were analyzed for network cross-talk (Table 4) .
The complex Abi1 (Abl Interactor 1)-Eps8 (EGFR pathway substrate 8)-SOS1 (Son of sevenless 1) is known to activate cytoskeletal changes [66] . In the EGFR network, it was found to be involved in most of the linear paths going to apoptosis and cell cycle progression. It has role in 30% of the linear paths of the phenotype actin reorganization (cytoskeletal changes). Vav is activated by EGFR and it acts as a guanine nucleotide exchange factor for Rac1 and Cdc42 [67] . The complexes Abi1-Eps8-SOS1, Vav2-EGFR, Cdc42-Rac-GTP and Cdc42-Rac-GDP are involved in linear paths of the inhibiting route of cell cycle progression. The signal coming from these complexes causes the transcriptional inhibition of p53 which inhibits directly cell cycle progression. Additionally, these four complexes are involved in both activating and inhibiting routes through apoptosis. On the other hand, the investigation of the linear paths including active MKK4 indicates that it has roles in inducing route towards apoptosis as well as inhibiting route to cell cycle progression (like the above complexes, MKK4 is also on the signaling path which inhibits the transcription of p53). p53 is found to be involved in the linear paths activating cell death through apoptosis in addition to the linear paths inhibiting cell proliferation through cell cycle progression indicating its tumor suppressor effect. It is known that MKK4 [68, 69] and p53 [70] [71] [72] have inhibitory roles in tumor growth in various cancer types.
In EGFR signaling network, the pathways ending with phenotypes; target genes transcription, tumorigenesis and mitogenesis are cross-talking via c-Src. Its tyrosine kinase activity has roles in the growth of tumor cells [73, 74] . c-Src complex with Pyk2 is involved in most of the linear paths of target genes transcription whereas the complex c-Src-Shc has roles in all linear paths going to tumorigenesis and mitogenesis (Tables 5 and 6 ).
The calcium signaling molecules (IP3, IP3R, Ca +2 , PYR) are shared by the pathways of actin reorganization, tumorigenesis and mitogenesis in the EGFR network. Calcium signaling is required for actin reorganization regulating intercellular adhesion between fibroblasts [75] . According to the results of our network decomposition analysis, calcium signaling may be one of the mechanisms by which EGF mediates the growth of tumor cells as also hypothesized [76] .
Another combination of cross-talking phenotypes is apoptosis, cell cycle progression, tumorigenesis and mitogenesis. The signaling pathways through these phenotypes use DAG (diacylglycerol) and PLCc (phospholipase Cc). DAG functions as a second messenger signaling lipid that regulates cell growth and apoptosis and is made by phospholipids [77, 78] . It was also shown that DAG has function in actin reorganization [79] .
Specific molecules
Beyond the shared molecules in linear paths leading to different phenotypes, specific (non-shared) molecules are also observed in linear paths of each phenotype in the EGFR signaling network (Table 5 ). These specific molecules are involved in more than 50% of the linear paths of one phenotype, but have roles in less than 50% of the linear paths through other phenotypes. Interestingly, actin reorganization is the only phenotype with no specific molecule, i.e. all of the molecules targeting this phenotype are also functioning in mechanisms targeting other phenotypes.
Apoptosis is an active form of cell death that eliminates damaged cells in organisms [80] . Expectedly, molecules deficient in apoptotic pathway result in uncontrolled cell growth (tumor) [58, 81] . Several anti-cancer drugs induce apoptosis [82] . Activation of p38 MAPK (mitogen-activated protein kinase) is associated with induction of apoptosis [83] . It was shown that MKK3 and MKK6 are essential for p38 MAPK activation [84] .
The cell cycle progression or cell-division cycle is the series of events in a eukaryotic cell until it replicates itself. c-Jun has been defined as a positive regulator of cell cycle progression (G1 to S phase) [85] . It has been shown that JNK signaling to c-Jun is required for cell proliferation with possible functions in S and G2-M phases [86] . MKK7 is a direct activator of JNKs involved in signaling in G2-M cell cycle progression [87] . It is known that MEKK1 is important in regulating cell survival [88] . Silencing MLK3 in mammalian cells inhibits cell proliferation of normal and tumor cells possibly affecting regulators of cell cycle progression [89] . EP2 and 4 are receptors of PGE2 (prostaglandin E2) which acts at all phases of the cell cycle to delay normal progression [90] .
STAT3 (Signal Transducer and Activator of Transcription) was found as one of the activators of the gene transcription phenotype of EGFR signaling as its name implies. STAT3 is a target of the c-Src Active Pyk2 MEKK1-GTP-Rac1/Cdc42
Active c-Src-Pyk2 MLK3-Rac1/Cdc42
Grb2-EGFR-active Pyk2 PGE2-active EP2/4 non-receptor tyrosine [91] . Pyk2 amplifies c-Src induced STAT3 activation [92] . Grb2 (Growth factor receptor bound protein) is essential for multiple cellular functions [93] . In this study, the complex Grb2-EGFR-Pyk2 was found to be specific to target genes transcription signaling pathway. Tumorigenesis is the formation of tumor as a result of uncontrolled cell proliferation. Signaling molecules specific to this phenotype is so crucial to develop drugs for the treatment of cancer since inhibition of these specific molecules does not significantly affect other phenotypes of the network. LPA (lysophosphatidic acid) was shown to be involved in rapid tyrosine phosphorylation of EGFR in tumor cells. It was proposed as a candidate tumor promoter [94] . LPA-LPA2 (receptor of LPA) was found as specific to tumorigenesis-mitogenesis phenotypes supporting the previous findings. Similarly PKC (Protein Kinase C) was reported as mediating EGF-induced growth of head and neck tumor cells by regulating MAPK [95] . It is also known that inhibition of PDK1 is effective in the treatment of cancer and tumors since it regulates several oncogenic pathways [96] [97] [98] . The final molecule specific to tumorigenesis-mitogenesis is the complex c-Src-Shc which has role in EGF-dependent cell cycle arrest and apoptosis in human epidermoid carcinoma A431 cells [99] . From the network, it was observed that this complex mediates the phosphorylation of ErbB1 ligand-active EGFR, and then the phosphorylated ligand-receptor complex undergoes tumorigenesis or mitogenesis as also hypothesized [100] .
All specific molecules found from linear path analysis (Table 5 ) were analyzed by pathway logic assistant [51] . These molecules were deleted one by one and all possible pathways were searched in the absence of deleted molecule targeting the relevant phenotype. The results are in parallel with the results of network decomposition analysis, specific molecules affect mostly their corresponding phenotypes (leaving small number of paths through phenotypes) having very little or no effects on other phenotypes.
Participation of molecules
The role of species in linear paths can be considered as an indication of their importance in the signal transduction since any state of the signaling network is a nonnegative combination of the linear paths. One can therefore comment about the importance of each molecule for each phenotype by its participation percentage in linear paths. The participation percentage of a molecule is the percentage of the linear paths (given in 2nd column of Table 2 ) the molecule contributed in. The top five molecules that participate in most of the linear paths of each phenotype in the EGFR signaling network (Table 6) were tested by pathway logic approach. The inhibitory effect of the molecules that participate in most of the linear paths through each phenotype, were observed in the resulting network when they were blocked. For instance, deletion of the molecules with 100% participation in the linear paths through tumorigenesis and mitogenesis (ErbB1 ligand-active EGFR, ATP, KDI, active c-Src-Shc) from the system resulted in an empty set when the network was targeted to these phenotypes.
The signaling complexes of Abi1-Eps8-SOS1 and Vav2-EGFR activate the conversion of Cdc42-Rac-GDP to Cdc42-Rac-GTP which is involved in two main routes (one activating and one inhibiting) through apoptosis. Therefore, to be able to activate or inhibit apoptotic state of the cell one should focus on the molecules involved in only activating or inhibiting route. Any disturbance in the above molecules affects both activating and inhibiting routes of apoptosis phenotype.
Similar to apoptosis, there is one activating and one inhibiting route of cell cycle progression. The tumor suppressor protein p53 negatively regulates cell cycle [101] . On the other hand, c-Jun signaling activates cell cycle [85] by inhibiting p53. The large participation percentages (97.6%) of these signaling molecules in the linear paths through cell cycle progression show their importance in agreement with the literature.
It is known that PLCb [102, 103] and calcium signaling [104] is important in mediating actin reorganization. In this case, one should be very careful in choosing targets to activate or inhibit actin reorganization because there are no molecules specific to this phenotype. Any modification can affect other phenotypes; the participation percentage of the molecules disturbed should be very small for the phenotypes other than actin reorganization.
Active Pyk2 and Grb2-EGFR-active Pyk2 activate c-Src converting to active c-Src-Pyk2 which is involved in STAT1 signaling through target genes transcription. Most of these highly participating signaling molecules are among the specific molecules for this phenotype of the EGFR network. Therefore it is possible to manipulate EGF-induced genes transcription by disturbing these specific molecules since they have small effects on other pathways in the network.
The analysis of the participation of molecules indicated that five signaling molecules are present in all the linear paths through tumorigenesis and mitogenesis (participation percentage of 100%). This result means that these phenotypes are strictly dependent on these molecules (low robustness). Particularly the complex, active c-Src-Shc is crucial since it is not involved in most of the linear paths of other phenotypes (specific to tumorigenesis and mitogenesis). Shc was shown to be a direct activator of the tyrosine kinase c-Src in vitro and in vivo [105] . c-Src has activation effect on tumorigenesis [106, 107] . Inhibition of c-Src may have an anti-cancer effect and several c-Src inhibitors are in development or in use as anti-cancer drugs [108, 109] but it has roles also in genes transcription phenotype and therefore the complex formation mechanism of c-Src with Shc should be considered as the key process in tumor growth. On the other hand, it was proposed that KDI1 can selectively inhibit proliferation effect of EGFR signaling and might become an anti-cancer drug [110] . However in the EGFR network KDI1 is also an inhibitor of the phosphorylation of the dimer of ErbB1 ligand-active EGFR. Since the phosphorylated complex is one of the hubs of the network KDI may not be selective inhibitor of tumorigenesis.
Conclusions
Over the recent years the large-scale signaling networks have been reconstructed with the rapid increase in genomic data. Here, we mathematically analyzed the structure of one of the most important signaling systems, EGFR network, to define crucial points for further researches in developing drugs against tumor cells. Using graph theory, the network diameter of EGFR network was found as 11 and its mean path length is 4.7 showing its small-world structure. The results of the graph theoretical analysis indicate that the connectivity distribution of the signaling molecules in the network has scale-free nature; four hubs (ErbB1 ligand-active EGFR, GTP, GDP and Gb/Gc) connect the rest of the molecules to the network (see Supplementary Figure) .
On the other hand computing linear paths from the ligands to the phenotypes allowed us to observe importance of each molecule for each phenotype. Known tumor suppressor proteins MKK4 and p53 were found to be involved in linear paths of inhibiting route of cell cycle and also in activating route of apoptosis showing their inhibition power in cell proliferation. Other important molecules are apoptosis specific p38 MAPK, MKK3, and MKK6 which can be activated when apoptosis is the desired mechanism for the cell. Because of their specificity to apoptosis (they are involved in more than 50% of the linear paths through apoptosis and in less than 50% of the linear paths through other phenotypes) any disturbance on these molecules affects mainly apoptosis with very little or no effect on the other phenotypes of EGFR network. In order to end with tumorigenesis, the EGFR-mediated signal transduction must pass over five signaling molecules (ErbB1 ligand-active EGFR, ATP, KDI1, c-Src, active c-Src-Shc) that are found to have roles in all linear paths through tumorigenesis. The tumorigenesis specific one is only the complex of c-Src-Shc whose inhibitors may be used in the design of anti-cancer drugs. Instead of inhibiting c-Src, disturbing the complex c-Src-Shc may have more selective effect on the cancer therapy.
